CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL）

Condition:   Leukemia, Lymphocytic, Acute Intervention:   Biological: CART-19 cells Sponsor:   The Affiliated Hospital of the Chinese Academy of Military Medical Sciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials